Thomson Reuters (TRI, TRI.TO) announced that it has acquired GeneGo for undisclosed financial terms. Thomson Reuters said that GeneGo will become part of the Healthcare & Science business of Thomson Reuters, effective immediately.
Thomson Reuters said that this acquisition enables it to provide pharmaceutical, biotechnology and academic research communities with solutions that provide better understanding of underlying mechanism of disease and potential therapies.
GeneGo is a provider of biology and disease information, analytics, and decision support solutions for pharmaceutical research and development. GeneGo is headquartered in San Diego and has offices in Moscow and Michigan.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.